X Square Capital, LLC Salarius Pharmaceuticals, Inc. Transaction History

X Square Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$0.16 - $0.42 $1,321 - $3,468	-8,258 Reduced 8.49%	89,000 $19,000
Q4 2021 Feb 14, 2022	SELL	$0.49 - $1.01 $1,666 - $3,434	-3,400 Reduced 3.38%	97,258 $48,000
Q3 2021 Nov 12, 2021	BUY	$0.8 - $1.15 $160 - $229	200 Added 0.2%	100,658 $103,000
Q2 2021 Aug 16, 2021	SELL	$1.02 - $1.52 $66,555 - $99,180	-65,250 Reduced 39.38%	100,458 $106,000
Q1 2021 May 13, 2021	BUY	$1.0 - $3.0 $107,850 - $323,550	107,850 Added 186.4%	165,708 $245,000

Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.34 $37,607 - $77,529	57,858 New	57,858 $53,000

Ticker SLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,244,650
Market Cap $5.1M
Description
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a ...

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on X Square Capital, LLC with notifications on news.